about
Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancersMutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer.Targeted Disruption of ALK Reveals a Potential Role in Hypogonadotropic HypogonadismMethylation detection oligonucleotide microarray analysis: a high-resolution method for detection of CpG island methylation.Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis.Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing data.Real-world data on nivolumab treatment of non-small cell lung cancer.TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies.High number of kinome-mutations in non-small cell lung cancer is associated with reduced immune response and poor relapse-free survival.Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers.Serum estradiol levels associated with specific gene expression patterns in normal breast tissue and in breast carcinomas.Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids.Years of life lost as a measure of cancer burden on a national levelExpression levels of uridine 5'-diphospho-glucuronosyltransferase genes in breast tissue from healthy women are associated with mammographic density.Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis.GoIFISH: a system for the quantification of single cell heterogeneity from IFISH images.Unique microRNA-profiles in EGFR-mutated lung adenocarcinomas.Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking.High levels of genomic aberrations in serous ovarian cancers are associated with better survival.Novel molecular tumor cell markers in regional lymph nodes and blood samples from patients undergoing surgery for non-small cell lung cancer.Two Distinct Categories of Focal Deletions in Cancer Genomes.Stereotactic body radiation therapy is effective and safe in patients with early-stage non-small cell lung cancer with low performance status and severe comorbidityDifferential DNA methylation analysis of breast cancer reveals the impact of immune signaling in radiation therapy.Osteopontin is a prognostic biomarker in non-small cell lung cancer.Targeting lung cancer through inhibition of checkpoint kinases.Gene expression profiles of breast biopsies from healthy women identify a group with claudin-low features.Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signalingThe MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma--differences in histological subtypesBreast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.NUT expression in primary lung tumoursPolymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 ExpressionTP53 gene mutations and protein accumulation in primary vaginal carcinomasMutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus loadTP53 mutations in early-stage ovarian carcinoma, relation to long-term survival.TP53 Mutation Spectrum in Smokers and Never Smoking Lung Cancer Patients.Detection of disseminated tumor cells in lymph nodes from patients with early stage non-small cell lung cancerClinical significance of disseminated tumour cells in non-small cell lung cancerA unique set of 6 circulating microRNAs for early detection of non-small cell lung cancer.Non-small cell lung cancer is characterised by a distinct inflammatory signature in serum compared with chronic obstructive pulmonary disease.Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity.
P50
Q25255387-FB0F3C42-2130-4975-B84E-FF0B01874F58Q27851720-2806FFC2-FC4E-4AFE-9A4A-597BF39CFEF3Q28547121-3B253697-8211-49CF-8770-6DF0BE7F3F7DQ30488766-CFDDB94E-92A3-49E7-990C-D1B8AF05A649Q30489645-8FD3A40E-4CA9-4E32-B35F-4BAAC17F042EQ30887494-2959322B-4CEA-41D0-8084-F3C3A38D8049Q31145059-416E2F68-16C4-4CFD-B70C-44C2A2D5B584Q33485646-F1685DB4-A2F3-4EAB-9933-2D7533AA1F7FQ33742810-5355A27A-51E8-476F-B032-1CC30507F97AQ33886925-1D9AD2A1-8EFB-4BE6-A41E-DD05FDECE3B6Q33980589-B5ED0FE0-5E9E-4953-8CC4-9C15068C5E7FQ34045543-2DF3D971-6A02-4F07-9D3B-0A820ABD6E5AQ34113539-65E594A3-09F0-428F-A3B9-380A4C2C7A49Q34173591-CA97DC9D-097E-47EA-B786-F5E7A4D2F886Q34196315-7ED884D6-9B0B-448C-BC66-30621AEE10B6Q34202981-D3DE44AA-5035-46B0-B0CD-1071F3F9FDE7Q34531091-26D4690A-6FE8-4FA9-9827-C960CEF4353FQ34545220-AE9A08F9-25E1-4F9E-ACE6-7EDB619482C0Q34571142-4A101A64-9A83-4867-9389-8DE321ADF7CEQ34720505-0B128DC6-E188-4488-92DE-252CD027710EQ34785286-1FEF81F7-0473-449A-81BD-2FEBA2F84508Q34859171-5E4485CC-DFAB-47B7-8760-38CBE73600BFQ34984011-53830804-F106-49F6-B345-4CDC16F7F6FCQ35038432-F79E04BA-168D-4E7E-92CB-36D96516E493Q35128547-65C7424A-126B-4D8A-B4AF-74C102F90B78Q35551926-33A9007B-5A05-4056-AC24-652E5561F73FQ35779345-58164E61-405C-4A6E-8FBB-A5C1D8B724C7Q35917825-37C2E613-86EE-4947-81B4-8A6469D0F264Q35940158-34788B43-BC48-4629-82B9-83719FB9098BQ36030365-A21304FB-06A3-4F7B-8DD9-AD9DAAA4DA27Q36066735-837BFCD0-FFFF-4DEF-9453-20371716E0F1Q36081911-84CD391B-E6D0-4885-8B43-2C23953EFD10Q36114776-44BE7134-684C-461E-9801-95868A36DE74Q36696616-832A7085-B4C1-4DFF-9C99-C05614B3D52AQ36889861-A90AEFEF-F6C3-43DF-BD7A-0889B1E6875EQ37018090-938AAA92-9650-4777-A7C1-F0CDAAC0E529Q37185823-2CAB85A7-0E39-4D3B-89AD-5EEB6DD8A24DQ37392954-2D249B27-D9B2-45AF-A3B4-6F8E20D4B868Q37463885-18BE9B7F-DB1A-41E9-9809-5911CA539764Q37592617-6CE853D7-3B8E-4DF6-AA88-05B24CDA766F
P50
description
Noors onderzoekster
@nl
hulumtuese
@sq
researcher
@en
հետազոտող
@hy
name
Åslaug Helland
@ast
Åslaug Helland
@en
Åslaug Helland
@es
Åslaug Helland
@nl
Åslaug Helland
@sl
type
label
Åslaug Helland
@ast
Åslaug Helland
@en
Åslaug Helland
@es
Åslaug Helland
@nl
Åslaug Helland
@sl
prefLabel
Åslaug Helland
@ast
Åslaug Helland
@en
Åslaug Helland
@es
Åslaug Helland
@nl
Åslaug Helland
@sl
P1053
H-3910-2015
P106
P21
P2287
P27
P2798
P31
P3829
P496
0000-0002-5520-0275
P569
2000-01-01T00:00:00Z